Spinal Cord Stimulators Market Significant Profits Estimated to be Generated by 2027

Introduction of affordable devices would pave huge opportunities for the global spinal cord stimulators market across developing economies. Customized spinal cord stimulators as per the requirements of an individual is expected to offer higher growth potential for leading market players. Specialists in healthcare settings are more likely to prescribe devices that are smaller in size, owing to their easy implantation and less painful surgical procedure.

In terms of value, an impressive 6.4% CAGR is estimated for the global spinal cord stimulators market by a report of Future Market Insights (FMI). In 2017, the market will account for nearly US$ 2,000 Mn in revenues; by 2027 this number is estimated to reach US$ 3,568.2 Mn. Growth of the market is primarily attributed to under penetration of potential market.

Spinal Cord Stimulators’ Ability of Reducing Opioid Analgesics Addiction to Drive the Market Growth

Majority of patients with chronic pain are increasingly depending upon opioid analgesics; however spinal cord stimulators is capable of reducing this addiction to a great extent. Entry of additional competitors in the market is expected to increase awareness about effectiveness of spinal cord stimulators. Spinal cord stimulators are comparatively more cost-effective than conventional medical management (CMM). Leading companies in the market are taking initiatives in improving technology for spinal cord stimulators. The aforementioned factors are estimated to drive growth of the global spinal cord stimulators market.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-2030

However, spinal cord stimulators have little access to evidence-based data in order to confirm effectiveness of these devices for management of chronic pain. Clinical validation of spinal cord stimulation is based on observational data, instead of verified data. This had led several private insurance companies to refuse reimbursement of costs, which in turn is impeding the market growth. In addition, complications associated with spinal cord stimulators, such as paresthesia- characterised by burning sensation, is further expected to restrain growth of the global spinal cord stimulators market.

Rechargeable Spinal Cord Stimulators will Remain Sought-After Product in the Market

In terms of value, rechargeable spinal cord stimulators are expected to remain sought-after product in the market. Revenues amassed from sales of rechargeable spinal cord stimulators are expected to reach US$ 2,530.4 Mn by 2027-end. In addition, sales of non-rechargeable spinal cord stimulators are anticipated to expand at 4.6% CAGR through 2027. Factors such as low battery life, and requirement of surgery for replacement of battery are restricting adoption of non-rechargeable spinal cord stimulators across the globe.

Application of spinal cord stimulators will remain highest in failed back surgery syndrome (FBSS), with sales estimated to surpass US$ 1,000 Mn in 2017. In addition, complex regional pain syndrome (CRPS) is projected to be the second-fastest growing application of spinal cord stimulators in the market. In terms of value, sales of spinal cord stimulators in CRPS are estimated to register 5.8% CAGR through 2027.

Adoption of Spinal Cord Stimulators to Witness Fastest Growth in Ambulatory Surgical Centres

Although hospitals will continue to be largest end-users of spinal cord stimulators, adoption will witness fastest growth in ambulatory surgical centres. Sales of spinal cord stimulators in hospitals are estimated to account for revenues worth US$ 627.9 Mn in 2017. Demand for spinal cord stimulators in ambulatory surgical centres is projected to exhibit 6.8% CAGR through 2027. In contrast, demand for spinal cord stimulators in clinics will remain sluggish in the market.

North America will continue to remain dominant in the global spinal cord stimulators market, with sales estimated to reach nearly US$ 3,000 Mn in revenues by 2027-end. Western Europe will remain the second-largest market for spinal cord stimulators, expanding at 6.1% CAGR through 2027. In addition, markets in Eastern Europe and Japan are estimated to exhibit parallel expansion at 6% CAGR through 2027.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-2030

Key market players identified in FMI’s report include Boston Scientific Corp., Medtronic Private Limited Company, St Jude Medical LLC, Nevro Corp, Nuvectra Corporation, Stimwave, Saluda Medical PTY Limited.

Dry Eye Syndrome Treatment Market is Expected to Witness a Steady Growth by 2027

Common forms of artificial tears are known for being quick-fix remedies to dry eye syndrome. Drops of artificial tears with CMC and HPMC formulations were a top-selling product in the global market for dry eye syndrome treatment. Now, new products formulated from derivations of hyaluronic acid are witnessing a soaring demand among dry eye syndrome patients from around the world. Future Market Insights’ latest study on the global dry eye syndrome treatment market predicts that developing products with hyaluronic acid formulations will be observed lucrative for the market’s overall expansion.

According to the study, the global market for dry eye syndrome treatment is anticipated to bring in over US$ 4,500 Mn revenues by the end of 2017. Growing preference of consumers towards preservative-free, single dose remedies on dry eye syndrome is expected to stimulate the market’s growth. The market is also expected to witness promising support from governments & private organisations through awareness campaigns and other initiatives in the field of ophthalmic care. Towards the end of 2027, the global market for dry eye syndrome treatment is predicted to expand robustly at 6.4% CAGR, roughly doubling the 2017 value estimations by reaching US$ 6,609.3 Mn.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1215

Dry Eye Syndrome Treatment Market – Key Trends

Public service programs in developed economies such as the US are providing eye care through volunteering ophthalmologists. These service are free of costs, successfully drawing attention of masses. Participation of government health authorities in such eye care drives is expected to promote the market’s growth. Reduced average length of stay (AVLOS) of dry eye syndrome treatment is also driving their demand among ophthalmology labs. Increasing demand for preservative-free eye care products, harmonised data collection, and availability of advanced labs to treat dry syndrome are also observed as key trends in the global dry eye syndrome treatment market.

Forecast Highlights & Key Players

The report has profiled key players in the global market for dry eye syndrome treatment. A competitive landscape on global dry eye syndrome treatment market includes companies such as Allergan Plc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Shire Plc., Santen Pharmaceutical Co Ltd., Valent Pharmaceuticals, Akorn, Inc., Abbott Laboratories, Thea Pharmaceuticals Limited, OASIS Medical, Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd., Reckitt Benckiser Group PLC., Medicom Healthcare Ltd., FDC Limited, Lupin Limited, Jamjoom Pharmaceuticals Co., and Sentiss Pharma Private limited.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-1215

Key highlights of the report include:

• North America and Western Europe will collectively dominate the market throughout the forecast period, however, the individual revenue share will incur a marginal decline towards the latter half of the forecast period
• Due to rising pollution levels and proximity of industrial contamination, the demand for dry eye syndrome treatment will surge significantly in Asia-Pacific excluding Japan region, reflecting fastest value growth at a CAGR of 7.4%
• In 2017 and beyond, cyclosporine will be observed as top-selling product on dry eye syndrome treatment, global sales of which will account for a vigorous revenue growth at 6.9% CAGR
• More than 60% of global dry eye syndrome treatment market will be dominated by sales through retail pharmacies, making them the largest distribution channel in the market.

Radiotherapy Devices Market Headed for Growth and Global Expansion by 2027

According to a recent Future Market Insights publication titled “Radiotherapy Devices Market: Global Industry Analysis & Opportunity Assessment 2017 – 2027”, the global radiotherapy devices market is estimated to move from a market valuation of just about US$ 4 Bn in 2016 to a figure of a little over US$ 10 Bn by the end of a 10 year period ending in 2027. This is reflective of a CAGR of 9.5% during the period 2017 – 2027. This significant growth is driven by several factors that impact revenue generation across the various regional markets.

Key drivers fuelling revenue growth of the global radiotherapy devices market

Rising instances of cancer across the globe: The adoption of western lifestyles and rise in unhealthy habits such as smoking, lack of physical activity, poor diet, etc. in economically developing countries will place a huge burden of cancer across the global populace. The demand for radiotherapy as a treatment option will be bolstered as a result.

Patient preference for minimally invasive techniques: Patients suffering from cancer, especially breast cancer (the second most common cancer in the world) are showing an increasing preference for minimally invasive treatment techniques and this is anticipated to fuel the growth in demand for radiotherapy.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1556

Growing popularity of radiotherapy devices among oncologists: Radiation therapy being the most popular therapy type in cancer management, oncologists across the world are showing an inclination towards radiotherapy devices, given the fact that more than 50% of cancer patients are likely to receive radiotherapy during the course of their treatment – either in primary disease management or for symptom control.

Global Radiotherapy Devices Market – Current Scenario & Future Outlook

The current scenario of the global radiotherapy devices market indicates a growing demand for radiotherapy devices in developing countries owing to ease of regulations and increasing product affordability. The radiotherapy devices market is highly consolidated with companies offering innovative products with latest technological advancements.

The future market outlook leans on minimally non-invasive technology that will generate the necessary demand in the global market. Among regions, North America will rule the global market for radiotherapy devices. Technological advancements coupled with growing instances of different types of cancers will make the global radiotherapy devices market a lucrative destination for investors.

Global Radiotherapy Devices Market: Segmental Forecast

The global radiotherapy devices market is segmented on the basis of product type into External Beam Radiotherapy Devices (sub-segmented into Linear Accelerators Devices and Proton Therapy Devices) and Internal Beam Radiotherapy Devices (sub-segmented into Brachytherapy); on the basis of end user into Hospitals, Ambulatory Surgical Centres, and Oncological Treatment Centres; and on the basis of region into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa.

By product type, External Beam Radiotherapy Devices will dominate the global radiotherapy devices market in terms of value share, estimated to hold over 75% market share in 2017 and over 85% market share by the end of the forecast period in 2027. This segment will register a high CAGR of 10.7% during the forecast period.

By end user, Hospitals will retain a dominant position in the global radiotherapy devices market with an estimated market valuation in excess of US$ 6,500 Mn by the end of 2027. Oncological Treatment Centres will hold the runner-up position, registering a CAGR of 8.7% during the forecast period.

Among the regional markets, North America will retain its pole position in the global market with a Y-o-Y growth rate of 8.1% in 2018 over 2017. Latin America will witness sluggish growth throughout the forecast period, with a CAGR of 6.4% recorded between 2017 and 2027.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-1556

Global Radiotherapy Devices Market: Competition Dashboard

The Future Market Insights report profiles some of the leading companies operating in the global radiotherapy devices market including Varian Medical Systems, Elekta AB, Accuray, Inc., C.R. Bard, Inc., IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens AG, Eckert & Ziegler Bebig, IsoRay, Inc., GE Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, AngioDynamics, Inc., Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, and Neusoft Medical Systems Co., Ltd.

Point-of-care Cholesterol Monitoring Device Market to Register Stable Expansion During 2018-2028

The prevalence of obesity and cardiovascular diseases is increasing due to modern-day sedentary life style, which is projected to surge the growth of the point-of-care cholesterol monitoring device market. Physical inactivity is the vital cause of cardiovascular diseases. It is almost affecting every section of the society. Wide spread incidence of cardiovascular diseases is expected to increase the demand for point-of-care cholesterol monitoring devices. The rising demand for point-of-care cholesterol devices is further expected to create enormous growth opportunities for the manufactures operating in the point-of-care cholesterol monitoring device market. People now prefer self-testing and daily monitoring of the condition of a disease, which has increased the adoption of point-of-care cholesterol monitoring devices.

According to the World Health Organization (WHO), it is estimated that nearly 17.9 million people die due to cardiovascular diseases worldwide, which accounts for 31% of all the deaths worldwide. The growing incidence of cardiac arrest, high blood pressure and strokes is also a factor expected to surge the demand for point-of-care cholesterol monitoring devices.

Numerous awareness programs to control and prevent high cholesterol are organized by the governmental organizations these days. For instance, the National Heart Disease and Stroke Prevention Program and Lipid Standardization Program are conducted by CDC (Centre for Disease control and prevention) for creating awareness among population. These programs are conducting trainings and campaigns to spread awareness regarding the ill effects of cholesterol and they also are giving education to the staff of the hospitals. In the recent years, the trend of healthy living and eating has increased due to  various government initiatives such as campaigns leading  to higher adoption of the cholesterol self-testing devices resulting in  the growth of point-of-care cholesterol monitoring device market in the forecast period. It is reported by CDC (Center for Disease control and prevention) that more than half the U.S population, i.e., 55% of U.S adults are taking medication for cholesterol-related health problems. Thus, rising incidence of cardiovascular diseases and complications due to high cholesterol is projected to trigger the growth of the global point-of-care cholesterol monitoring device market.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7773

Point-of-care monitoring devices are helpful in critical situations requiring rapid turn-around time of test results for clinical decision-making. But there are many challenges associated with POCT, mainly related to quality assurance. The tests performed in laboratories are carried out by trained professionals under GLP (Good lab practices) and certain measures are implemented for delivering acute results for patient safety.

The company has segmented the point-of-care cholesterol monitoring device market on the basis of product type, technology, application, end user and regions. Based on product type, the point-of-care cholesterol monitoring device market has been segmented into point-of-care instruments and testing kits. Testing kits segment is projected to hold large share in the point-of-care cholesterol monitoring device market. According to the company, the testing kits segment accounted for a revenue share of over 60% in the global point-of-care cholesterol monitoring device market in 2017.

Geographically, the global point-of-care cholesterol monitoring device market has been segmented across regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding China & Japan, China, Japan and MEA. North America, followed by Asia Pacific, is expected to hold substantial revenue share in the global point-of-care cholesterol monitoring device market.  Many local players in Japan are focusing on increasing their market share in emerging regions such as MEA and APECJ.

Based on end users, the point-of-care cholesterol monitoring device market is segmented into hospitals, diagnostic centers & laboratory, ambulatory surgical center and home care sittings.  The diagnostic centre & laboratory segment is expected to hold large share in the point-of-care cholesterol monitoring device market.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7773

The company’s report tracks some of the key companies operating in the point-of-care cholesterol monitoring device market, which include F. Hoffmann-La Roche Ltd., Acon Laboratories, Inc., Abaxis, Inc., Abbott Laboratories, SD Biosensor, Inc., Jant Pharmacal Corporation, DiaSys Diagnostic Systems GmbH, Bioptik Ltd., and Fitech UK Ltd., among others.

Vagus Nerve Stimulator Market: High Maintenance and Device Costs to Restrain Adoption of Vagus Nerve Stimulators

Over three decades ago, it was discovered that vagus nerve’s intermittent electrical stimulation develops a series of neural process inhibition, which is responsible to alter the activities of the brain and terminate seizures. This investigation paved the way for development of a device called vagus nerve stimulator. The neuro stimulator device reduces the intensity and frequency of seizures to almost half during the management of refractory seizures. In a clinical study, it has been found that after 48 hours of stimulation of the vagus nerve, vagus nerve stimulator can promote neurogenesis in the dentate gyrus of rat hippocampus. Recent studies have proved the effectiveness of vagus nerve stimulator in management of obesity in patients with depression. Vagus nerve stimulator has also gained significant popularity with positive results in epilepsy surgery and treatment-resistant depression. According to the latest research by the company, the global vagus nerve stimulator market is projected to account for over US$ 1.129.5 Mn, in terms of value, by 2028 end. The report on the global vagus nerve stimulator market is expected to witness significant growth potential with an average Y-o-Y growth rate pegged at 10.6% through 2028.

Over the years, the burden of neurological diseases is increasing in the emerging countries. This has increased the usage of implantable vagus nerve stimulator in neurological patients, since its inception in 2005. The WHO estimates that neurological disorders are responsible for 4.5–11% of all illnesses in low- and high-income economies. This prevalence is relatively high as compared to cancer, respiratory and gastrointestinal disorders. It is expected that the disease burden is expected to increase further over the forecast period. In addition, neurological disorders contributed to 92 million disability-adjusted life-years in 2005 and are projected to be 103 million in 2030 worldwide.

The vagus nerve stimulator implanted devices are currently being approved for the treatment of refractory epilepsy and depression only. However, results from many ongoing clinical studies are in pipeline, awaiting to notify about the appropriate use of vagus nerve stimulator devices in other applications. The market for vagus nerve stimulator is expected to grow significantly due to favorable reimbursement policies in the developed countries. As per the Center for Medicare & Medicaid Services database, many vagus nerve stimulator devices are covered under the reimbursement criteria. Besides, many health systems are also putting in efforts to provide these products at affordable prices. Manufacturers are investing in their products so as to meet the expectations of the end users. As implantable devices are associated with possible epileptic side-effects, a paradigm shift towards increase in demand for external vagus nerve stimulator devices is witnessed in the recent years. Additionally, the external vagus nerve stimulator is more effective in terms of treatment as well as affordable for the patients.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7759

Macroeconomic indicators such as increasing healthcare expenditure and prioritizing service quality will increase the adoption of quality equipment and consequently drive the growth of the global vagus nerve stimulator market. According the current GDP forecast report by IMF, healthcare spending will increase by 6% Y-o-Y.

On the grey side, the use of implantable vagus nerve stimulators is associated with major complications, for instance, occurrence of cardiac dysrhythmias both at the time of implantation as well as post-operative implantation. After examining the effects in 130 patients implanted with a vagus nerve stimulators between 2000 and 2013, it was observed that there is an increased response rate from 22.1 to 43.8% from the first to fifth year of vagus nerve stimulators implantation. Though the functional anatomy and physiology of the left and right vagus nerve is consistent, the cause of this complication remains uncertain.

The report offers a comprehensive taxonomy of vagus nerve stimulator market based on product type, end user, application type and region. Based on product type, the vagus nerve stimulator market is segmented into implantable and noninvasive (tVNS) based. According to the company, the implantable segment accounted for over 99.3% revenue share in the global vagus nerve stimulator market in 2017. However, the growing popularity of noninvasive ones (vagal nerve stimulator) might limit the segment’s growth in the near future. The vagus nerve stimulator finds application in pain management, epileptic seizures, obesity, depression and anxiety. By application, epileptic seizures is projected to be the major application segment in terms of revenue in the global vagus nerve stimulators market. These vagus nerve stimulators are used by hospitals, ambulatory surgical centers, specialty clinics and home care settings. The vagus nerve stimulator market has been analysed across regions of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan and MEA. Asia Pacific is expected to be the most lucrative regional market for vagus nerve stimulator during the forecast period.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7759

The report tracks some of the key companies operating in the global vagus nerve stimulator market, including ElectroCore LivaNova LLC, Cerbomed GmbH, ReShape Lifesciences, Inc. NERVANA LLC, ReShape Lifesciences, Inc. Beijing PINS Medical Co., Ltd, Parasym Health, etc.

Global Recombinant Vaccines Sales to Cross US$ 6 Bn in 2019

A new study by the company titled ‘Recombinant Vaccines Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028′, has listed out the key points being considered by Recombinant Vaccines companies to emerge and stay sustainably profitable in the long run in the Recombinant Vaccines market. The APEJ Recombinant Vaccines market is expected to expand at a CAGR of close to 7%, and is expected to remain as a main sink market for revenues. Western Europe is expected to remain as the main source market for Recombinant Vaccines, as most of the Recombinant Vaccines facilities are located in this region. However, with the increasing demand optimized & sustainable healthcare in countries such as China and India, and various countries of Asia Pacific and Middle-East, is fueling the growth of Recombinant Vaccines market.

The report finds that there is an increasing focus on improving accessibility to recombinant vaccines. Vaccines are needed by 80% of the population and less than 20% has access to them. Vaccines are becoming an engine of growth for the pharmaceutical industry and given greater focus on preventive healthcare. However, there exists huge demand gap for vaccines demand and supply across the world. Newer and faster vaccines are entering the market however at and inflated pricing. Until and unless it is listed with providers such as Global Vaccines Alliance Imitative (GAVI) or the Bill and Melinda Gates Foundation, their access is limited in the developing countries The World Health Organization has noted that 60 vaccines are in shortfall in terms of availability in developing countries

UNICEF, GAVI and PAHO are focusing on emerging countries for boosting availability of recombinant vaccines at low subsidized rates. Three main strategies followed by these organizations are partnerships with emerging economies and local manufacturers, if any; accelerated uptake and differentiated pricing; and improving cold chain facilities for better supply chain management

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7757

Hospitals, private clinics & dispensaries, retail pharmacies & others distributing Recombinant Vaccines are the primary point of contact for patients experiencing infectious disease and others. Private clinics & dispensaries sub-segment under the end users segment for Recombinant Vaccines market, accounted for over 40% revenue share in the overall Recombinant Vaccines market in 2017. Growing demand for cost-effective diagnostic options success in clinical studies for developing a Recombinant Vaccines is expected to fuel the growth of the global Recombinant Vaccines market over the forecast period.

Activities across the Recombinant Vaccines manufacturers are acquisitions, collaborations, sharing and product development. The top activity associated with Recombinant Vaccines manufacturers is joint collaboration with various organizations in order to spread awareness, further development, and promote the efficiency of Recombinant Vaccines.

Rising focus on cost-effective diagnosis using Recombinant Vaccines is expected to boost the growth of the Recombinant Vaccines market. Recombinant Vaccines manufacturing companies focusing on spreading awareness about Recombinant Vaccines and marketing Recombinant Vaccines through campaigns and joint research studies is expected fuel the growth of the Recombinant Vaccines market during the forecast period. However, Recombinant Vaccines could experience stiff competition from alternative procedures and modalities that are well established and adopted by healthcare providers.

Development of recombinant vaccines and commercial production is a complex procedure. Lead time required in production of a commercial lot of vaccines ranges from few months to several years depending on the complexity of vaccine composition, manufacturing process complexity, etc. It has been noted that to get a vaccine into the market it takes roughly about twelve years. Most important recombinant vaccines have entered the market in the last decade. The pipeline though strong marks presence of just few players which indicates tough market entry for new smaller players. Quality check and production maintenance coupled with stockpiling and unpredictable demand worsens costing scenario.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7757

Some of the key Recombinant Vaccines companies analyzed in this report titled Recombinant Vaccines market include GlaxoSmithKline Biologicals, MERCK & CO., INC, Dynavax Technologies Corporation, Sanofi Pasteur, Bharat Biotech, Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., LG Chem, Sinovac Biotech Ltd, Pfizer, C.H. Boehringer Sohn AG & Co.KG.

Endoscopy Visualization System Market: Diagnostic Area-wise Analysis: Maximum Opportunities Exist for GI Tract Endoscopy Visualization Systems

The increasing prevalence of gastrointestinal, urology, gynecology and respiratory disorders, growing ageing population, changing lifestyle and hygiene have led to health problems worldwide. Gastrointestinal, urology, gynecology and respiratory disorders present a large patient pool undergoing endoscopic surgeries every year, especially in the emerging economies. These factors are expected to boost the growth of the endoscopy visualization system market over the forecast period. According to the latest report published by the company, the global endoscopy visualization system market is projected to account for over US$ 2,167.8 Mn, in terms of value, by 2028 end. The report further projects significant growth of the endoscopy visualization system market with an average CAGR of 7.3% through 2028.

Gastrointestinal cancer is one of the common diseases in Asia and Americas, with the prevalence rate around 48.8 per 1,000 hospitalized cases. The increasing prevalence of other diseases such as gastrointestinal bleeding, stomach cancer, and functional gastrointestinal diseases is also expected to increase the demand for endoscopy procedures. Ageing, obesity, hygiene and changing lifestyle are the prime factors responsible for gastrointestinal, urology, gynecology and respiratory disorders. Population aged 65+ years is growing worldwide. With increasing prevalence of such disorders, the demand for minimally invasive surgery is also increasing, which is expected to drive the growth of the endoscopy visualization system market. Healthcare initiatives by the governments have surged the awareness level and increased the number of patients opting for minimally invasive endoscopy surgeries. This factor, in particular, is projected to play an instrumental role in driving the growth of the endoscopy visualization system market over the forecast period.

An endoscopy visualization system is used in the visualization and interpretation of the high definition endoscopic images of all endoscopy surgeries. The endoscopy visualization system provides improved endoscopic images. It is used to examine many types of endoscopic surgeries such as general surgery, gastroenterological surgery, respiratory surgery, urology, obstetrics/gynecology, orthopedic surgery, endocrine surgery, pediatric surgery, and anesthesiology, among other surgical treatments. The endoscopy visualization system is used for endoscopic procedures in which the endoscope is inserted through the opening of the body or through a small incision, which leads to less chances of infection as compared to the traditional operative procedures. The images obtained from the visualization system can help the surgeon to better understand and find the perfect treatment for the disorder. Also, the use of endoscope reduces the healthcare expenditure. The endoscopy procedures take short time, reduce the time of hospital stay and have low risk of complication. The above-mentioned post-operative benefits of the endoscope are expected to drive the demand for endoscopy visualization systems.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7596

The stringent rules and regulations by the U.S. Food and Drug Administration (FDA) and the European Commission for the new product launch are expected to hinder the growth of the endoscopy visualization system market. The increasing government spending in North America is expected to boost the growth of the endoscopy visualization system market over the forecast period. The healthcare infrastructure in Latin America is growing rapidly. With a rapidly growing healthcare infrastructure, the demand for advanced medical devices and minimally invasive procedures is also increasing in the region. The European Society of Gastrointestinal Endoscopy has drawn specific regulations and guidelines for endoscope users with technical and legal implications. The new European ESGE guidelines help concur healthy competition in the market and boost the revenue of the global endoscopy visualization system market. The active healthcare landscape in the Asia Pacific region is projected to boost the growth of the medical devices industry. Government initiatives for Foreign Direct Investment (FDI) through third-party investors in the healthcare industry for infrastructure development and growth of the industry are also expected to propel the demand for advanced procedures and consequently the growth of the endoscopy visualization system market. The Asia-Pacific ex. Japan endoscopy visualization system market is estimated to create an incremental $ opportunity worth US$ 342.5 Mn between 2018 and 2028.

The company has segmented the global endoscopy visualization system market by product type into high-range endoscopy visualization system, mid-range endoscopy visualization system and low-range endoscopy visualization system based on their price range. In terms of revenue, the high-range endoscopy visualization system in the global endoscopy visualization system market is expected to hold major share over the forecast period owing to advanced features and clear and high definition endoscopic images. However, the mid-range endoscopy visualization system and low-range endoscopy visualization system segments in the global endoscopy visualization system market are expected to witness high growth in low- and middle-income countries, in terms of revenue, through 2028. Further, the company segmented endoscopy visualization system by area type and end-user. The areas are gastrointestinal tract, respiratory tract, ear, urology tract, female reproductive tract and through small incision. In terms of revenue, gastrointestinal tract is expected to hold major share over the forecast period owing to increasing prevalence of gastrointestinal disorder. The end-users are hospitals, ambulatory surgical centers, specialty clinics and diagnostic imaging centers. In end-user, hospital is expected to hold major share owing to availability of advanced technology and facilities.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7596

The report tracks some of the key participants operating in the global endoscopy visualization system market, such as Olympus Corporation, Karl Storz GmbH & Co KG., Pentax Medical Company (Hoya Corporation), Stryker Corporation, Fujifilm Holding Corporation, Conmed Corporation, Boston Scientific Corporation, DePuy Synthes (Johnson & Johnson Services, Inc.), Smith & Nephew and Richard Wolf GmbH.

Esophagoscopes & Gastroscopes Market will Register a CAGR of 5.3% through 2028

The growing prevalence of gastrointestinal diseases has led to a major increase in the esophagoscopes & gastroscopes market. Esophagoscopes & gastroscopes have a major role in endoscopy surgical procedures. There has been significant increase in the number of other diseases such as gastrointestinal bleeding, cancer, etc., which is boosting the esophagoscopes & gastroscopes market. Poor diets, genetics, and urbanization are the major factors responsible for the cause of gastrointestinal diseases. Apart from diseases, an increase in the number of minimally invasive surgeries is playing an important role in driving the esophagoscopes & gastroscopes market. The risks associated with minimally invasive surgeries are very less, which has increased the number of minimally invasive surgeries, owing to the safety and their efficacy, which is driving the esophagoscopes & gastroscopes market.

The geriatric population is more prone to lifestyle diseases and disorders, such as cardiac disorders, diabetes, and obesity, which are the leading causes of illnesses, globally. A rise in the incidence rate of lifestyle diseases in the geriatric population is expected to boost the esophagoscopes & gastroscopes market. Ease in FDA clearances in the endoscope medical device market is also a major factor expected to drive the growth of the esophagoscopes & gastroscopes market.

Original Equipment Manufacturers (OEMs) lay greater emphasis on collaborations and partnerships with local and regional players so that they can increase their sales and after sales services for esophagoscopes & gastroscopes.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-3120

Companies in the esophagoscopes & gastroscopes market are also focusing on establishing new set-ups to support manufacturing and sales activities through collaborations and partnerships with regional players and third-party service vendors.

The affordability of endoscopy procedures is a major problem for a huge chunk of the population, due to the absence of health insurance and limited government support policies that cover endoscopy treatment in developing countries such as India and China. This absence of social health insurance, along with the exclusionary provision of private health insurance schemes is a major factor limiting the esophagoscopes & gastroscopes market.

Inadequate reimbursement policies are expected to restrain the growth of the esophagoscopes & gastroscopes market. Shortage of healthcare professionals can also limit the growth of the esophagoscopes & gastroscopes market.

Owing to economic pressure, overall healthcare spending in Latin America has declined. However, local governments are trying to improve public healthcare systems, due to which, the healthcare market is expected to grow at an average rate, along with the esophagoscopes & gastroscopes market.

FMI has segmented the esophagoscopes & gastroscopes market into rigid endoscopes and flexible endoscopes. Rigid endoscopes give an opportunity to reach internal cavities and organs. A rigid endoscope is inserted through a small incision made in the skin to reach an internal organ. A rigid endoscope is fitted with one or more extra channel through which operating instruments are to be passed.

A flexible endoscope is used for the diagnosis of the internal parts of the body. In a flexible endoscope, an operating handle is used to control the manipulating tip of the site when required. In terms of revenue, the product segment in esophagoscopes & gastroscopes market is expected to hold significant share over the forecast period. Flexible endoscopes have a larger market share as compared to rigid endoscopes.

On the basis of end user, the esophagoscopes & gastroscopes market has been divided into hospitals, ambulatory surgical centres, specialty clinics, and diagnostic centres. The hospitals segment has the largest market share in the esophagoscopes & gastroscopes market.

The esophagoscopes & gastroscopes market has also been studied according to various regions. The esophagoscopes & gastroscopes market has been analyzed across the regions of North America, Latin America, Europe, Asia Pacific, and MEA. North America, followed by Asia Pacific, is expected to hold substantial revenue share in the global esophagoscopes & gastroscopes market. Companies are focusing on increasing their market share in emerging regions such as CIS & Russia, APEJ, etc.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-3120

FMI’s report tracks some of the key companies operating in the esophagoscopes & gastroscopes market, such as Shanghai AoHua Photoelectricity Endoscope Co., Ltd., Olympus Corporation, Pentax Medical Company Fujifilm Holdings Corp., and Karl Storz GmbH & Co. KG.

Demand for Compact Systems Likely to Boost the Cardiac Ultrasound Systems Market Growth

Growing incidences of cardiac diseases owing to growing risk factors, such as sedentary lifestyle, fatty food intake, diabetes, growing geriatric population and others, is increasing the number of referrals to cardiac clinics, which is resulting in the growth of the cardiac ultrasound systems market. According to the latest research conducted by the Future Market Insights (FMI), the global cardiac ultrasound systems market is anticipated to account for over US$ 2,024.9 Mn, in terms of value, by 2028 end. The report further projects significant growth potential for the market, which is expected to expand at a CAGR of 5.9% through 2028.

The cardiac ultrasound systems market has been segmented by product type, end users and regions. On the basis of product type, the cardiac ultrasound systems market has been segmented into cart/trolley cardiac ultrasound devices and compact/handheld ultrasound devices. On the basis of end users, the cardiac ultrasound systems market has been segmented into hospitals & clinics, diagnostic imaging & surgical centers, ambulatory surgical centers and others. Based on product type, the cart/trolley cardiac ultrasound devices segment is expected to account for the largest share of 82.6% in 2018. However, the compact/handheld ultrasound devices is expected to grow at the highest CAGR of 6.7% during the forecast period.

The growth of the global cardiac ultrasound systems market is being primarily driven by the rise in the number of patients suffering from cardiac diseases, growing geriatric population and growing screening rates. According to the World Health Organization, cardiovascular diseases (CVDs) account for 17.9 million deaths every year, representing 31% of all global deaths.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7692

According to the Center for Disease Control and Prevention, almost 610,000 people die of heart diseases in the United States each year and almost 735,000 U.S. citizens suffer from a heart attack each year.

However, high cost is the biggest barrier to achieve full cardiac ultrasound systems market potential. Installation of high-end ultrasound systems requires significant capital investments and costs around US$ 55,000 to US$ 100,000. This can be attributed to the limited product availability due to less number of players in the market. Also, due to lack of government grants for installation of these systems in the Asia Pacific and Latin American countries, end users, such as hospitals and diagnostic centers, are reluctant to adopt these systems. This is primarily due to lack of awareness among patients about cardiac ultrasound systems, which negatively affects its uptake.

This cardiac ultrasound systems report assesses the trends that are driving the growth of each segment of the market at the global as well as regional level and offers potential takeaways that could prove substantially useful for manufacturers planning to enter the cardiac ultrasound systems market.

North America is expected to be the dominant regional market for cardiac ultrasound systems and accounted for a high revenue share in 2017. The U.S. market is expected to account for a large share and is expected to grow at a CAGR of 5.4% over the forecast period. The developing regions, led by India and China, are expected to drive the future cardiac ultrasound systems market owing to their developing economies and expanding healthcare infrastructure.

The Middle East and Africa market is dominated by the gulf economies owing to their high per capita income and high public healthcare expenditure. The development of large hospital complexes in the Gulf nations will drive market adoption of cardiac ultrasound systems products during the forecast period.

FMI’s report tracks some of the key companies operating in the Cardiac Ultrasound Systems market, such as Hitachi, Ltd., Analogic Corporation, Toshiba Corporation, Esaote SpA, Samsung Medison Co., Ltd, FUJIFILM Holdings Corporation, Mindray Medical International Ltd. and GE Healthcare, among others.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7692

Advancements and availability of portable diagnostic ultrasound systems is driving the use of “bedside ultrasonography” which is expected to give a boost to the growth of the Cardiac Ultrasound Systems market during the forecast period. Companies are focused on the development of products which offer economic as well as clinical relevance to the overall business.

Vein Finder Market: Excellence in Customer Satisfaction and Increasing Adoption of Vein Finder

Growing aging and obese population is leading to increased health problems worldwide. People aged 65 and above receive the highest percentage of medications. Today, nearly 30% of the world’s population is obese. Disease incidences are also increasing in newborns and children due to lifestyle changes and hygiene issues. These increasing health problems create a large patient pool each year, especially in emerging countries.

According to WHO, around 421 Mn people get hospitalized every year. Hospitalized patients require IV insertion and need to give blood samples for testing. Geriatric, obese and pediatric populations experience pain during IV insertion and blood collection due to vein inaccessibility. Vein finders provide better vein visualization, thereby leading to no pain or discomfort during venepuncture and cannulation. This factor will boost the growth of the Vein Finder market during the forecast period. According to the latest report published by FMI, the global market is projected to account for over US$ 86.8 Mn, in terms of value, by 2028 end. The report further projects that the market will grow at an average CAGR of 10.7% through 2028.

In hospitals, peripheral venous access is one of the common procedures performed. Most of the patients need peripheral cannula for IV therapy and it is estimated that more than 1 Bn venipuncture procedures are performed every year to obtain blood samples for testing. Pediatric patients have sensitive arteries and veins due to which IV insertion and obtaining blood sample becomes very difficult. Also, finding veins is difficult in obese and dark skin patients. Treatments may cause damage and alteration of subcutaneous fat and reduce the visualization of peripheral veins in these patients. The vein finders play a very important role as they help the physicians and nurses overcome the difficulties faced during venipuncture. This factor, in particular, is likely to play an instrumental role in driving the growth of the concerned market.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-7640

A Vein finder is an innovative biomedical device that helps healthcare professionals find veins for intravenous insertion and blood withdrawal. These devices creates a real-time visual mapping of veins on the skin surface using near infrared rays. These devices are comfortable to use and can conveniently be used in hospitals or laboratories. Vein finders help healthcare professionals reduce the time taken for venepuncture and cannulation. Also, they reduce the pain and stress experienced patients during venepuncture and cannulation.

Vein finders use different technologies to locate the veins of a patients. Ultraviolet vein finders use the high powered red LED flashlight to locate veins under the skin. Infrared devices map the veins based on various wavelengths. These devices use the near-infrared light reflection to create a map of the veins. Ultrasound Vein finders scan a patient’s skin and displays the veins on a large screen. The infrared segment accounted for over 54.8% revenue share in the global market in 2017. Though the market is expected to show robust growth, a lack of trained healthcare professionals might limit the growth of the concerned market.

Stringent rules and regulations set by the U.S. Food and Drug Administration (FDA) and the European Commission regarding new product launches may hinder the growth of the Vein Finder market. Increasing government spending in North America is expected to boost the growth of the concerned market. Increasing geriatric population, active healthcare landscape and availability of low cost vein finder devices in the Asia Pacific region are anticipated to give a boost to the market in the region. Asia-Pacific ex. Japan is estimated to create incremental $ opportunity worth US$ 19.7 Mn between 2019 and 2028.

The global Vein Finder market has been segmented into portable vein finders and benchtop vein finders. In terms of revenue, the portable segment is expected to hold major share during the forecast period as these devices are portable and thus, user-friendly in nature. On the other hand, the benchtop segment is expected to show stagnant growth due to high cost. On the basis of technology, the market is segmented into ultraviolet, infrared and ultrasound. In terms of revenue, infrared segment is expected to show high growth over the forecast period. On the basis of end users, the market is segmented into hospitals, clinics, ambulatory surgical centers, diagnostic centers and path labs, veterinary clinics, home care settings and blood banks. The hospital segment is expected to show highest revenue growth as increasing number of people are getting hospitalized due to increasing health problems.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-7640

The report tracks some of the key companies operating in the Vein Finder market, such as AccuVein Inc., Christie Medical Holdings, Koninklijke Philips N.V, Osang Healthcare Co. Ltd, Teleflex Inc. (Acq. VueTek Scientific, LLC.), TransLite, LLC, ZD Medical, Vivolight, Venoscope LLC and Shenzhen Bestman Instruments Co., Ltd.

Bone Densitometer Devices Market Estimated to Experience a Hike in Growth by 2026

Future Market Insights predicts the US$ 277 Mn global bone densitometer devices market to witness a hike in revenues at a passive CAGR of 3.5% over the next decade. In its recent market outlook titled “Bone Densitometer Devices Market: Global Industry Analysis and Opportunity Assessment, 2016–2026,” the company forecasts that the market for bone densitometer devices will be valued at US$ 390.6 Mn by the end of 2026. Over 2016-2026, bone densitometer devices market is likely to grow passively; however, a few prominent trends will continue to drive market revenues through 2026.

Prevalence of Osteoporosis and Vitamin D deficiency Building Market – Ageing Remains Primary Catalyst

Driven primarily by rising incidences of osteoporosis and other bone-related disorders, the market will also be fuelled by the ensuing awareness about growing osteoporosis incidences. Increased emphasis on preventive healthcare, early diagnosis, and quality treatment are identified to be among the key factors spurring the demand for bone densitometer devices globally. Ageing, resulting in almost threefold risks of acquiring wrist, hip, and vertebral osteoporosis, will remain a major market growth catalyst.

Moreover, increasing prevalence of vitamin D and calcium deficiency disorders will also escalate the demand in near future. Burgeoning cancer prevalence is boosting the number of patients undergoing chemotherapy, which is further identified to affect their bone density in the long run. This will be another driver to growth of bone densitometer market. Evidently increasing integration of DXA into routine health check-ups will also escalate market growth over the forecast period.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-733

Developed Markets Marching Ahead, Asian Countries to Witness Robust Growth

North America will continue to represent the largest market for bone densitometer devices, followed by Western Europe and Asia Pacific. Latin America and MEA will witness relatively lower growth rates.

• The U.S. will continue to dominate North American market with nearly 75% revenue share of the region and by 2026, North America is expected to surpass a value of US$ 204 Mn, grabbing over half of the market revenue share.
• APEJ will be the most lucrative, fastest growing market for bone densitometer devices. Led by China, followed by India and ANZ, this region will approach US$ 61 Mn in 2026, expanding at CAGR of 4.2% over 2016-2026. The Chinese market for bone densitometer devices is expected to exceed US$ 20 Mn in revenues, whereas India’s revenues are estimated at over US$ 17 Mn by 2026 end.

Product-wise Segmentation

By product, the global consumption of axial bone densitometer will possibly account for the revenues of US$ 272.3 Mn in 2026. This segment will grow at an estimated 3.7% of CAGR, gaining over 150 BPS during 2016-2026 against peripheral bone densitometer segment. Axial bone densitometer devices will continue to gain higher traction due to superior accuracy and precision, accounting for around 70% value share by 2026. Peripheral bone densitometer segment is also likely to witness steady adoption, as it allows short scan time and lesser exposure to radiation.

Technology-wise Segmentation

Based on technology, dual energy X-ray absorptiometry (DXA) segment is expected to remain dominant with nearly 65% share by 2026 end. This segment will possibly attain a value worth US$ 253 Mn in 2026, expanding at the highest CAGR of 3.7%. Quantitative ultrasound (QUS) segment is anticipated to register a 3.2% of CAGR, reaching over US$ 88 Mn by 2026 end.

End-user-wise Segmentation

In terms of end-user, hospitals segment will remain the largest consumer of bone densitometer devices, accounting for revenues worth US$ 252.3 Mn in 2026. Diagnostic centres, the second largest end-user segment with an estimated value of around US$ 80 Mn by 2026, is expected to witness the highest CAGR of 3.8% over the forecast period. Hospitals are likely to capture around 65% share in 2026, whereas diagnostic centres will bag over 20% share in 2026 market revenues.

Beetling Trends and Upcoming Opportunities Fostering Demand for Bone Densitometer Devices

Increasing adoption of DXA, coupled with growing prominence of ultrasound technology, will be important trends in market. Improving healthcare infrastructure and extended reimbursement for osteoporosis treatment are also highlighted as influential trends. While flourishing medical tourism initiatives will remain a growing trend, strategic M&A activities will continue to trend among key players.

Manufacturers are likely to witness several untapped opportunities in developing Asian markets, which are primarily driven by exploding population and immense healthcare burden. Governments are also increasingly supporting the market through favourable bone density measurement awareness programs.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-733

Product Portfolio Extension on Key Players’ Minds

According to Future Market Insights, leading manufacturers are currently focusing on strategic M&A for extended product portfolios. In addition, they are also targeting advanced product innovation and new product launches to maintain a strong market presence. Some of the key players in the global bone densitometer devices market are GE Healthcare, Hologic, Inc., Beammed, Ltd., Osteosys Co. Ltd., Diagnostic Medical System SA, Swissray International, Inc., Medonica Co. Ltd., and Osteometer Meditech, Inc.